NDC 58602-853 – Guaifenesin

Guaifenesin 600 mg/1 · Tablet, Extended Release · Oral

Human Otc Drug

Product NDC58602-853

Product details

Brand name
Guaifenesin
Generic name
Guaifenesin
Labeler
Aurohealth LLC
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA210453
Marketed since
August 13, 2020
Listing expires
December 31, 2026
Pharmacologic class
Expectorant

Active ingredients

Uses, dosage, side effects and warnings for Guaifenesin →

Package NDC codes (6)

Package NDCDescriptionSince
58602-853-121 BOTTLE in 1 CARTON (58602-853-12) / 40 TABLET, EXTENDED RELEASE in 1 BOTTLEAug 13, 2020
58602-853-211 BOTTLE in 1 CARTON (58602-853-21) / 100 TABLET, EXTENDED RELEASE in 1 BOTTLEAug 13, 2020
58602-853-731 BOTTLE in 1 CARTON (58602-853-73) / 20 TABLET, EXTENDED RELEASE in 1 BOTTLEAug 13, 2020
58602-853-961 BLISTER PACK in 1 CARTON (58602-853-96) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACKAug 13, 2020
58602-853-972 BLISTER PACK in 1 CARTON (58602-853-97) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACKAug 13, 2020
58602-853-985 BLISTER PACK in 1 CARTON (58602-853-98) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACKNov 1, 2022

Other Guaifenesin products